Hallucination in a Seizure Patient Using Levetiracetam: A Case Report | Zendy

Dhana Ratna Shakya | Zendy; Abhishek Dutta | Zendy; R Gautam | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hallucination in a Seizure Patient Using Levetiracetam: A Case Report

Author(s) -

Dhana Ratna Shakya,

Abhishek Dutta,

R Gautam

Publication year - 2012

Publication title -

case reports in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.2

H-Index - 20

eISSN - 1687-9627

pISSN - 1687-9635

DOI - 10.1155/2012/706243

Subject(s) - levetiracetam , auditory hallucination , medicine , antiepileptic drug , electroencephalography , anesthesia , adverse drug event , adverse effect , epilepsy , audiology , pediatrics , psychiatry , pharmacology , psychosis

Levetiracetam, a relatively new antiepileptic drug (AED), is used mainly as adjuvant and less as monotherapy of seizure. Though rare, Levetiracetam is reported to induce hallucination. To highlight the potential of this adverse drug event, we report a seizure-case that had auditory hallucination with Levetiracetam. A 32-year lady had 7-year history of unresponsive spells which increased in the last year, also occurred while asleep and were diagnosed as “generalized seizure” with video-EEG. With gradual optimization of Levetiracetam to 2250 mg, she continuously heard distressing sound of saw cutting wooden blocks. After 3-day continuous auditory hallucination, Levetiracetam had to be changed to sodium valproate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research